Table 2. Summary of the experimental conditions and determined affinities in Figure 3.
Figure 31 | Probe ligand | Target | Exptl data | [Cu]tot (µM) | [L]tot (µM) | p[Cu+] at2 | logKD(P)3 | |
---|---|---|---|---|---|---|---|---|
Start | End | |||||||
b | Fs | CopK | Solid dots | 31.0 | 90 | 9.1 | 10.3 | <−9 |
Empty dots | 15.5 | 45 | 8.8 | 10.0 | <−9 | |||
c | Fs | CopK | Solid dots | 30.0 | 280 | 10.9 | 11.7 | −11.2 |
Empty dots | 15.0 | 140 | 10.6 | 11.4 | −11.2 | |||
d | Fz | CopK | Solid dots | 30.0 | 120 | 11.2 | 11.8 | −11.2 |
Empty dots | 15.0 | 60 | 10.9 | 11.9 | −11.2 | |||
f | Bca | hGrx1 | Solid dots | 34.0 | 200 | 13.9 | 15.0 | <−14 |
Empty dots | 34.0 | 100 | 12.7 | 14.5 | <−13 | |||
g | Bca | hGrx1 | Solid dots | 38.0 | 500 | 14.9 | 15.4 | −15.5 |
Empty dots | 19.0 | 250 | 14.6 | 15.2 | −15.5 | |||
h | Bcs | hGrx1 | Solid dots | 32.0 | 80 | 14.7 | 15.8 | −15.6 |
j | Bca | Atx1 | Triangles | 40 | 500 | 14.8 | 15.8 | <−16 |
Pluses | 40 | 100 | 12.1 | 14.4 | ||||
WNL5–6 | Circles | 40 | 500 | 14.8 | 15.8 | <−16 | ||
Crosses | 40 | 100 | 12.1 | 14.3 | ||||
k | Bcs | Atx1 | Solid dots | 36 | 500 | 17.5 | 18.0 | −17.7 |
Empty dots | 300 | 17.0 | 17.9 | −17.7 | ||||
l | Bcs | WLN5–6 | Solid dots | 36 | 500 | 17.5 | 18.0 | −17.6 |
Empty dots | 200 | 16.4 | 17.6 | −17.6 |
In Mops or KPi buffer (pH 7.0) containing excess reductant NH2OH and/or ascorbate;